DailySpaceK-One Technology Berhad
0111 · ACE Market创业板（ACE Market） · annual reports 2023 to 2025, 1140 entries read2023 至 2025 年报，共读出 1140 条
The company这家公司
K-One Technology Berhad provides electronics manufacturing services and cloud computing services, and in 2024 added the distribution and supply of healthcare and medical devices and hygiene-care products.K-One Technology Berhad 提供电子制造服务与云计算服务，并在 2024 年新增医疗保健设备及卫生护理产品的分销与供应业务。
Source: annual report 2024, page 14.出处：2024 年年报第 14 页。
In 2025, cloud computing services generated RM141,627,356, electronic products generated RM83,102,276, medical and healthcare devices and consumables generated RM16,255,846, and research, design and development generated RM2,180,162, out of total revenue of RM243,165,640.2025 年，在 RM243,165,640 的总营业额中，云计算服务贡献 RM141,627,356，电子产品贡献 RM83,102,276，医疗保健设备及耗材贡献 RM16,255,846，研究、设计与开发贡献 RM2,180,162。
Source: annual report 2025, pages 94, 113.出处：2025 年年报第 94、113 页。
By destination, Malaysia contributed RM99,028,583 of revenue in 2025, Asia excluding Malaysia RM77,647,441, Europe RM48,808,596, and the United States of America RM11,393,435. In 2025, two major international customers contributed RM66,813,198, representing more than 27% of revenue.按地区划分，2025 年马来西亚贡献营业额 RM99,028,583，除马来西亚外的亚洲地区 RM77,647,441，欧洲 RM48,808,596，以及美利坚合众国 RM11,393,435。2025 年，两家主要国际客户贡献 RM66,813,198，占营业额超过 27%。
Source: annual report 2025, pages 94, 115.出处：2025 年年报第 94、115 页。
Executive Chairman Ir. Edwin Lim Beng Fook and Chief Executive Officer Dato' Martin Lim Soon Seng are brothers. In the 2023 analysis of shareholdings, Lim Beng Fook held 126,772,273 shares (15.24%) and Lim Soon Seng held 108,618,078 shares (13.05%).执行主席 Ir. Edwin Lim Beng Fook 与首席执行员 Dato' Martin Lim Soon Seng 为兄弟关系。在 2023 年股权架构分析中，Lim Beng Fook 持有 126,772,273 股（15.24%），Lim Soon Seng 持有 108,618,078 股（13.05%）。
Source: annual report 2023, pages 8, 37, 113.出处：2023 年年报第 8、37、113 页。
In the 2025 analysis of thirty largest depositors, Public Nominees (Tempatan) Sdn Bhd held 2,510,000 shares (0.30%) in a pledged securities account for Lee Khoon Beng, and Kenanga Nominees (Tempatan) Sdn Bhd held 2,329,200 shares (0.28%) pledged for Lee San Meng. Peggy Liew Li Choo was appointed as an Independent Non-Executive Director on 6 June 2025.在 2025 年三十名最大股东名册中，Public Nominees (Tempatan) Sdn Bhd 在 Lee Khoon Beng 的抵押证券账户下持有 2,510,000 股（0.30%），Kenanga Nominees (Tempatan) Sdn Bhd 在 Lee San Meng 的抵押账户下持有 2,329,200 股（0.28%）。Peggy Liew Li Choo 于 2025 年 6 月 6 日获委任为独立非执行董事。
Source: annual report 2025, pages 8, 123.出处：2025 年年报第 8、123 页。
External revenue by activity, 20252025 年各业务对外营业额占比
Source: annual report 2025, page 94.出处：2025 年年报第 94 页。
Major events大事记
Source: annual report 2023, pages 9, 77.出处：2023 年年报第 9、77 页。
Source: annual report 2023, page 13.出处：2023 年年报第 13 页。
Source: annual report 2024, pages 57, 62.出处：2024 年年报第 57、62 页。
Source: annual report 2024, page 16.出处：2024 年年报第 16 页。
Source: annual report 2025, page 61.出处：2025 年年报第 61 页。
Source: annual report 2025, page 29.出处：2025 年年报第 29 页。
Source: annual report 2025, page 16.出处：2025 年年报第 16 页。
Revenue, profit and operating cash营业额、盈利与营运现金
Assets, liabilities, equity and cash资产、负债、权益与现金
20232023 年
In 2023, operating activities generated net cash of RM16,494,080. The group paid cash consideration of RM4,932,036 to acquire a 36% equity interest in P.T. Gasia Pasific Indo, spending net cash of RM4,587,374 after deducting cash acquired. Capital expenditure included RM4,405,237 for purchase of property, plant and equipment and RM2,018,600 for purchase of intangible assets. The group maintained a debt-free position with no borrowings.2023 年，营运活动产生现金净额 RM16,494,080。集团支付现金对价 RM4,932,036 收购 P.T. Gasia Pasific Indo 36% 股权，扣除取得的现金后净流出现金 RM4,587,374。资本支出包括购买物业、厂房与设备的 RM4,405,237 以及购买无形资产的 RM2,018,600。集团保持无借款的零负债状态。
Source: annual report 2023, pages 14, 16, 60, 77.出处：2023 年年报第 14、16、60、77 页。
20242024 年
In 2024, operating activities generated net cash of RM7,151,295. Capital expenditure included RM1,782,584 for purchase of property, plant and equipment and RM1,640,648 for purchase of intangible assets. The group received RM1,339,253 in government grants from the Malaysian Investment Development Authority for specific machineries, and paid RM211,079 for lease liabilities. The group had no borrowings.2024 年，营运活动产生现金净额 RM7,151,295。资本支出包括购买物业、厂房与设备的 RM1,782,584 以及购买无形资产的 RM1,640,648。集团因购买特定机器收到来自马来西亚投资发展局（MIDA）的政府补助 RM1,339,253，并偿还租赁负债 RM211,079。集团没有借款。
Source: annual report 2024, pages 16, 68, 94.出处：2024 年年报第 16、68、94 页。
20252025 年
In 2025, operating activities generated net cash of RM2,981,886. Purchase of property, plant and equipment was RM4,523,211, while purchase of intangible assets was RM50,000. An impairment loss of RM1,165,143 was recognised on ventilator development costs upon commercialisation reassessment. Payment of lease liabilities was RM225,932. The group ended the year with no borrowings and cash and cash equivalents of RM45,357,147.2025 年，营运活动产生现金净额 RM2,981,886。购买物业、厂房与设备的支出为 RM4,523,211，购买无形资产支出为 RM50,000。在重新评估呼吸机开发成本后，因商业化确认了 RM1,165,143 的减值亏损。偿还租赁负债支付 RM225,932。集团期末无借款，现金与现金等价物为 RM45,357,147。
Source: annual report 2025, pages 16, 67, 68, 82.出处：2025 年年报第 16、67、68、82 页。
Across the three years三年合看
Across the three reports, the company declared no dividends, stating an intention to conserve cash for business expansion and potential acquisitions. Goodwill of RM22,675,946 arising from the acquisition of subsidiaries is tested for impairment every year. The group had no borrowings in all three financial years, with cash and cash equivalents of RM39,923,781 in 2023, RM47,999,045 in 2024 and RM45,357,147 in 2025.在三份年报中，公司均未宣布派发股息，说明旨在保留现金以促进业务扩张和潜在收购。收购子公司产生的商誉 RM22,675,946 每年须进行减值测试。集团在三个财政年度均无借款，2023 年、2024 年和 2025 年的现金与现金等价物分别为 RM39,923,781、RM47,999,045 和 RM45,357,147。
Source: annual report 2023, pages 10, 108; annual report 2024, pages 12, 119; annual report 2025, pages 12, 115, 118.出处：2023 年年报第 10、108 页；2024 年年报第 12、119 页；2025 年年报第 12、115、118 页。
Still to be spent尚未支出的承诺
At the end of 2025, freehold land carried at RM1,433,333 and office buildings carried at RM2,006,667 were pledged to secure unutilised credit facilities. On 16 March 2026, subsidiary K-One Venture entered into a shareholders' agreement to establish joint venture AI Robomac Sdn Bhd.截至 2025 年底，账面值 RM1,433,333 的永久地契土地及 RM2,006,667 的办公楼已抵押以担保未动用的信贷额度。2026 年 3 月 16 日，子公司 K-One Venture 签署股东协议成立合资公司 AI Robomac Sdn Bhd。
Source: annual report 2025, pages 16, 78.出处：2025 年年报第 16、78 页。
Four years of figures四年数字
Group figures, in RM, as printed in the statements.集团数字，单位令吉，照财务报表所印。
| Group集团 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| RM令吉 | RM令吉 | RM令吉 | RM令吉 | |
| Revenue营业额 | 164,845,452 | 167,250,299 | 201,744,002 | 243,165,640 |
| Profit before tax税前盈利 | 737,495 | 147,830 | 1,867,577 | 3,239,442 |
| Profit for the financial year本年度盈利 | (100,015) | 231,553 | 620,068 | 1,024,548 |
| Net cash from operating activities营运活动所得现金净额 | (929,863) | 16,494,080 | 7,151,295 | 2,981,886 |
| Purchase of property, plant and equipment购买物业、厂房与设备 | (3,302,086) | (4,405,237) | (1,782,584) | (4,523,211) |
| Purchase of intangible assets购买无形资产 | (44,652) | (2,018,600) | (1,640,648) | (50,000) |
| Total assets总资产 | 162,706,750 | 171,989,133 | 189,000,423 | 194,141,280 |
| Total liabilities总负债 | 48,096,706 | 55,532,896 | 72,434,841 | 76,657,766 |
| Total equity总权益 | 114,610,044 | 116,456,237 | 116,565,582 | 117,483,514 |
| Cash and cash equivalents现金与现金等价物 | 37,375,998 | 39,923,781 | 47,999,045 | 45,357,147 |
On a computer, hover over a figure for the report and page it is printed on.在电脑上把鼠标移到数字上，可看到它印在哪份年报的哪一页。
Said and done说过的与做到的
| What the reports said年报说要做的 | What later reports show之后年报显示的 | Status状态 |
|---|---|---|
| NASA-JPL licensed ventilator rebranded as Medkaire expected to roll out towards year end 2024 once clinical reports are submitted to MDA for approval获 NASA-JPL 授权并更名为 Medkaire 的呼吸机预计在向 MDA 提交临床报告获批后于 2024 年底前推出 | The rollout was deferred to the second half of 2025 in the 2024 report, and in 2025 an impairment of RM1,165,143 was recognised on ventilator development costs upon commercialisation reassessment.2024 年报中推出时间推迟至 2025 年下半年，而在 2025 年对呼吸机开发成本进行商业化重新评估后计提了 RM1,165,143 的减值亏损。 Source: annual report 2023, pages 10, 17; annual report 2024, pages 10, 11; annual report 2025, pages 13, 16, 82.出处：2023 年年报第 10、17 页；2024 年年报第 10、11 页；2025 年年报第 13、16、82 页。 | Delayed; development costs impaired in 2025延迟；开发成本于 2025 年计提减值 |
| Potential follow through production of solar energy ancillary products in 2024 following breakthrough into the renewable energy industry进军可再生能源行业后，预计于 2024 年跟进生产太阳能辅助产品 | Later reports do not record production commencing for solar ancillary products; in 2025 the group stated it was exploring the installation of a rooftop solar power system.后续年报未记录太阳能辅助产品投产；2025 年集团表示正探讨安装屋顶太阳能发电系统。 Source: annual report 2023, pages 10, 18; annual report 2025, page 24.出处：2023 年年报第 10、18 页；2025 年年报第 24 页。 | Not mentioned again as commencing production未再提及开始投产 |
| Planned installation of rainwater harvesting system at manufacturing facilities计划在制造厂房安装雨水收集系统 | The 2024 report noted 30% completion with two 1,000-litre tanks installed in Ipoh, and the 2025 report confirmed installation of rainwater harvesting systems had been completed.2024 年报记录怡保厂区安装两个 1,000 公升储水罐且完成 30%，2025 年报确认雨水收集系统安装已完成。 Source: annual report 2023, page 36; annual report 2024, pages 30, 42; annual report 2025, page 24.出处：2023 年年报第 36 页；2024 年年报第 30、42 页；2025 年年报第 24 页。 | Completed已完成 |
| Cloud business targets to complete implementation of a new back office system in 2024云计算业务目标于 2024 年完成新后勤系统的实施 | The Cloud business implemented a new back-office system and a Project Management system in 2024.云计算业务于 2024 年实施了新后勤系统及项目管理系统。 Source: annual report 2023, page 33; annual report 2024, pages 39, 42.出处：2023 年年报第 33 页；2024 年年报第 39、42 页。 | Completed已完成 |
| Board hopes to achieve the target of 30% women directors within the next 3 years董事会希望在未来 3 年内实现 30% 女性董事的目标 | Peggy Liew Li Choo was appointed as Independent Non-Executive Director on 6 June 2025, but the 2025 report repeated the target of 30% female representation within the next 3 years.Peggy Liew Li Choo 于 2025 年 6 月 6 日获委任为独立非执行董事，但 2025 年报重申了未来 3 年内达到 30% 女性代表的目标。 Source: annual report 2023, page 35; annual report 2025, pages 8, 41.出处：2023 年年报第 35 页；2025 年年报第 8、41 页。 | Still in progress仍推进中 |
What the reports leave open年报留下待看的事
- Whether the EMS business can recover from its loss of RM3.7 million in 2025 (2024: loss of RM2.4 million); the group plans to revise selling prices to existing customers, whose payments are mostly in US dollars, to offset the ringgit's rise.EMS 业务能否从 2025 年 RM3.7 million 的亏损（2024 年亏损 RM2.4 million）中恢复；由于客户大多以美元付款，集团计划向现有客户调整售价，以抵销令吉升值的影响。
Source: annual report 2025, pages 13, 15, 18.出处：2025 年年报第 13、15、18 页。
- Commercialisation progress of the Medkaire ventilator after the RM1,165,143 impairment loss recognised on development costs in 2025.在 2025 年对开发成本计提 RM1,165,143 减值亏损后，Medkaire 呼吸机的商业化进展。
Source: annual report 2025, pages 16, 82.出处：2025 年年报第 16、82 页。
- Revenue growth in the emerging healthcare business, which held exclusive Malaysian distribution rights for Diversey products and CIGA Healthcare test-kits.新兴医疗保健业务的收入增长，该业务拥有 Diversey 产品及 CIGA Healthcare 检测试剂盒在马来西亚的独家分销权。
Source: annual report 2025, pages 15, 19, 35.出处：2025 年年报第 15、19、35 页。
- Inflow of funds from the potential exercise of 208,001,709 free warrants listed in January 2025 to finance working capital and growth initiatives.2025 年 1 月上市的 208,001,709 份免费凭单潜在行权所带来的资金流入，用于支持营运资金与增长计划。
Source: annual report 2024, page 16; annual report 2025, pages 61, 91.出处：2024 年年报第 16 页；2025 年年报第 61、91 页。
Facts as printed in the company's annual reports, with the page of each; no rating and no advice. Built 2026-10-28.内容为公司年报所印的事实，并注明页码；不评级，不构成投资建议。生成日期 2026-10-28。